• Zyus Life Sciences closed the second tranche of its non-brokered private placement Nov. 6, 2026, raising CAD 50,000.
• Insiders purchased all 111,110 units at CAD 0.45 each, bringing total proceeds across two tranches to approximately CAD 250,000.
• Each unit comprises one common share and half a common share purchase warrant, exercisable at CAD 0.59 for 24 months.
• The offering targets up to CAD 3 million; an additional tranche is expected to close shortly.
• Proceeds will fund general corporate and working capital purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zyus Life Sciences Corporation published the original content used to generate this news brief via CNW (Ref. ID: 202611061949CANADANWCANADAPR_C7439) on November 07, 2026, and is solely responsible for the information contained therein.